The peptide hormone kisspeptin, signaling via its receptor, KISS1R, decreases hepatic steatosis and protects against metabolic dysfunction-associated steatotic liver disease (MASLD). Here, KISS1R is linked to metabolic dysfunction-associated steatotic liver disease.